These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
74 related items for PubMed ID: 8429536
1. Stability of cefdinir (C1-983, FK482) to extended-spectrum plasmid-mediated beta-lactamases. Payne DJ, Amyes SG. J Med Microbiol; 1993 Feb; 38(2):114-7. PubMed ID: 8429536 [Abstract] [Full Text] [Related]
5. Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin. Neu HC, Saha G, Chin NX. Antimicrob Agents Chemother; 1989 Oct; 33(10):1795-800. PubMed ID: 2589845 [Abstract] [Full Text] [Related]
9. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics]. Susić E. Acta Med Croatica; 2004 Oct; 58(4):307-12. PubMed ID: 15700687 [Abstract] [Full Text] [Related]
10. Characterization of a new plasmid-mediated extended-spectrum beta-lactamase from Serratia marcescens. Kunugita C, Higashitani F, Hyodo A, Unemi N, Inoue M. J Antibiot (Tokyo); 1995 Dec; 48(12):1453-9. PubMed ID: 8557603 [Abstract] [Full Text] [Related]
12. Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins. Matsumoto Y, Ikeda F, Kamimura T, Yokota Y, Mine Y. Antimicrob Agents Chemother; 1988 Aug; 32(8):1243-6. PubMed ID: 3056257 [Abstract] [Full Text] [Related]
13. In vitro activity of loracarbef against TEM extended-spectrum beta-lactamase-producing Escherichia coli strains and its interaction with the enzymes. Prinarakis EE, Tzouvelekis LS, Legakis NJ. Chemotherapy; 1998 Aug; 44(4):260-4. PubMed ID: 9681202 [Abstract] [Full Text] [Related]